Novartis employs more than 119,000 associates worldwide. The ability to attract, grow and keep talented people is vital for us to execute our strategy and keep developing innovative products that produce better results for patients. In the context of an increasingly challenging healthcare environment and rapid change at Novartis, we are reinforcing our culture, boosting our associates’ skills and building a diverse workforce with talented leaders.
The success of Novartis Pharmaceuticals Corporation (NPC) is made possible by the members of our Innovative Medicines Executive Committee (IMEC). Our NPC Innovative Medicines Executive Committee (IMEC) consist of respected industry leaders and visionaries who share a common passion for innovation and excellence in execution.
Under the leadership of Chief Executive Officer Joseph Jimenez, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies. ECN members are chosen by the Board of Directors.